Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Syrians face common enemy across frontlines: surging COVID-19

Published 09/30/2021, 09:58 AM
Updated 09/30/2021, 10:17 AM
© Reuters. FILE PHOTO: A medical staff assists patients suffering from the coronavirus disease inside the COVID-19 ward of a hospital in the opposition-held Idlib, Syria September 26, 2021. REUTERS/Mahmoud Hassano

IDLIB, Syria (Reuters) - In both the Syrian capital Damascus and parts of the country that have rebelled against its rule during a decade of war, people are facing the same enemy: COVID-19.

Intensive care beds have filled up at hospitals across the fractured nation this month because of a COVID-19 surge, piling pressure on health systems shattered by conflict and amid slow vaccination campaigns.

"There are many cases that need intensive care and unfortunately often we either have to wait for a patient to be moved from the wing, or to die so another can replace them," said Absi Mohamad Fouad, a doctor at a hospital in Idlib in the rebel-held northwest.

Some 4 million people live in the northwest, 1.7 million of them in camps for those uprooted by the conflict.

"The hospitals can no longer absorb this attack," Fouad added, saying that younger people were being hit harder by this wave. All 70 beds were in use at his hospital and there was an oxygen shortage, he said.

More than 1,000 cases a day are being recorded in the northwest, often up to 1,500, said Mark Cutts, U.N. deputy regional humanitarian coordinator for the Syria crisis.

But with testing kits in short supply, the real figure could be a lot higher, he said.

"We are extremely concerned. This is the biggest spike we have seen since the beginning of the pandemic in northwest Syria. It is similar in other parts of Syria."

"It's a disastrous situation. The hospitals are completely overwhelmed. People are dying because of a lack of oxygen," he said. Less than 2% of people in the northwest have been vaccinated.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Vaccination campaigns have made slow progress more widely in Syria, where the overall population stands at around 18 million.

In the northwest, some 117,000 people have received a shot, according to local health authorities. The government's campaign has vaccinated some 450,000 people.

At a Damascus hospital this week, medics in disposable gowns and face masks tended to patients hooked up to oxygen.

The situation was so bad at one point that patients were sent to Homs for treatment, said Tawfik Hasaba, head of the Syrian ambulance service. "Today one of the infected patients who needed care was transported to Hama." Homs is about 140km (85 miles) from Damascus, and Hama 180km.

The biggest daily tally of infections in this wave according to the Syrian government was 442.

Official figures say there have been more than 31,000 infections and over 2,100 coronavirus-related deaths reported in Syria since the pandemic began last year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.